204 related articles for article (PubMed ID: 31803963)
1. Clinical features and treatment of epidermal growth factor inhibitor-related late-phase papulopustular rash.
Tohyama M; Hamada M; Harada D; Kozuki T; Nogami N; Monden N; Kajiwara T; Nishina T
J Dermatol; 2020 Feb; 47(2):121-127. PubMed ID: 31803963
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus coagulase-positive skin inflammation associated with epidermal growth factor receptor-targeted therapy: an early and a late phase of papulopustular eruptions.
Amitay-Laish I; David M; Stemmer SM
Oncologist; 2010; 15(9):1002-8. PubMed ID: 20709888
[TBL] [Abstract][Full Text] [Related]
3. Targeted tumour therapy induced papulopustular rash and other dermatologic side effects: a retrospective study.
Yalici-Armagan B; Ayanoglu BT; Demirdag HG
Cutan Ocul Toxicol; 2019 Sep; 38(3):261-266. PubMed ID: 31010330
[No Abstract] [Full Text] [Related]
4. Prophylactic Topical Treatment for EGFR Inhibitor-Induced Papulopustular Rash: A Randomized Clinical Trial.
Amitay-Laish I; Prag-Naveh H; Ollech A; Davidovici B; Leshem YA; Snast I; Popovtzer A; Purim O; Flex D; David M; Brenner B; Ben-Aharon I; Peled N; Hodak E; Stemmer SM
Dermatology; 2021; 237(6):988-994. PubMed ID: 33378750
[TBL] [Abstract][Full Text] [Related]
5. Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
Štulhofer Buzina D; Martinac I; Ledić Drvar D; Čeović R; Bilić I; Marinović B
Acta Dermatovenerol Croat; 2016 Apr; 24(1):70-2. PubMed ID: 27149134
[TBL] [Abstract][Full Text] [Related]
6. Topical doxycycline foam 4% for prophylactic management of epidermal growth factor receptor inhibitor skin toxicity: an exploratory phase 2, randomized, double-blind clinical study.
Shacham Shmueli E; Geva R; Yarom N; Hubert A; Keynan R; Kedem TH; Eini M; Tamarkin D; Shirvan M
Support Care Cancer; 2019 Aug; 27(8):3027-3033. PubMed ID: 30607677
[TBL] [Abstract][Full Text] [Related]
7. EGFR inhibitor-induced skin reactions: differentiating acneiform rash from superimposed bacterial infections.
Braden RL; Anadkat MJ
Support Care Cancer; 2016 Sep; 24(9):3943-50. PubMed ID: 27117557
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Tumor Response to Cetuximab and Panitumumab in 116 Patients and a Review of Approaches to Managing Skin Toxicity.
Jaka A; Gutiérrez-Rivera A; López-Pestaña A; del Alcázar E; Zubizarreta J; Vildosola S; Arregui MA; Sarasqueta C; Lobo C; Tuneu A
Actas Dermosifiliogr; 2015; 106(6):483-92. PubMed ID: 25798804
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
10. Retarded low-dose doxycycline for EGFR or MEK inhibitor-induced papulopustular rash.
Vaubel J; Livingstone E; Schadendorf D; Zimmer L
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1685-9. PubMed ID: 24422792
[TBL] [Abstract][Full Text] [Related]
11. Late epidermal growth factor receptor inhibitor-related papulopustular rash: a distinct clinical entity.
Sibaud V; Tournier E; Roché H; Del Giudice P; Delord JP; Hubiche T
Clin Exp Dermatol; 2016 Jan; 41(1):34-7. PubMed ID: 25959005
[TBL] [Abstract][Full Text] [Related]
12. A prospective crossover pilot study to evaluate the use of a topical wound gel in patients with cutaneous toxicity caused by epidermal growth factor receptor inhibitors.
Wong SF; Lindgren A; Mummaneni M; Byun T; Vasko C; Arenos R; Alexson E; Osann K
J Support Oncol; 2010; 8(5):202-8. PubMed ID: 21086877
[TBL] [Abstract][Full Text] [Related]
13. [A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant
Wu X; Yu H; He LY; Wang CQ; Xu HM; Zhao RQ; Jing CM; Chen YH; Chen J; Deng JK; Shi J; Lin AW; Li L; Deng HL; Cai HJ; Chen YP; Wen ZW; Yang JH; Zhang T; Xiao FF; Cao Q; Huang WC; Hao JH; Zhang CH; Huang YY; Ji XF
Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):628-634. PubMed ID: 32842382
[No Abstract] [Full Text] [Related]
14. Bacterial brothers in arms: cooperation of Staphylococcus aureus and Pseudomonas aeruginosa during antimicrobial exposure.
Lenhard JR; Smith NM; Quach CD; Nguyen TQ; Doan LH; Chau J
J Antimicrob Chemother; 2019 Sep; 74(9):2657-2665. PubMed ID: 31219553
[TBL] [Abstract][Full Text] [Related]
15. [ANTIBIOTICS SENSITIVITY OF STAPHYLOCOCCUS AUREUS, PSEUDOMONAS AERUGINOSA AND BACTERIA OF BURKHOLDERIA CEPACIA COMPLEX, PERSISTING IN LUNGS OF PATIENTS WITH MUCOVISCIDOSIS (MV)].
Avetisyan LR; Chernukha MY; Shaginyan IA; Kapranov NI; Siyanova EA; Medvedeva OS; Kondratieva EI; Alekseeva GV; Krasovsky SA; Usacheva MV; Amelina EL
Zh Mikrobiol Epidemiol Immunobiol; 2015; (6):3-10. PubMed ID: 26950982
[TBL] [Abstract][Full Text] [Related]
16. Infection in burn patients in a referral center in Colombia.
Ramirez-Blanco CE; Ramirez-Rivero CE; Diaz-Martinez LA; Sosa-Avila LM
Burns; 2017 May; 43(3):642-653. PubMed ID: 28185802
[TBL] [Abstract][Full Text] [Related]
17. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals.
Rogues AM; Dumartin C; Amadéo B; Venier AG; Marty N; Parneix P; Gachie JP
Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1389-95. PubMed ID: 17994520
[TBL] [Abstract][Full Text] [Related]
18. Current Recommendations and Novel Strategies for the Management of Skin Toxicities Related to Anti-EGFR Therapies in Patients with Metastatic Colorectal Cancer.
Annunziata MC; De Stefano A; Fabbrocini G; Leo S; Marchetti P; Romano MC; Romano I
Clin Drug Investig; 2019 Sep; 39(9):825-834. PubMed ID: 31264159
[TBL] [Abstract][Full Text] [Related]
19. Changes in strategies for optimal antibacterial therapy in cystic fibrosis.
Ratjen F
Int J Antimicrob Agents; 2001 Feb; 17(2):93-6. PubMed ID: 11165111
[TBL] [Abstract][Full Text] [Related]
20. Multicentric study in five African countries of antibiotic susceptibility for three main pathogens: Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa.
Zerouali K; Ramdani-Bouguessa N; Boye C; Hammami A;
J Chemother; 2016 Aug; 28(4):266-72. PubMed ID: 25363146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
